Clinical Trials Browser

Interventional × Head and Neck Squamous Cell Cancer × cabozantinib × Clear all

NCT03667482 2024-07-23

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Phase 1 Completed

Head and Neck Squamous Cell Cancer